Lataa...
Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues
Conflicting results have been reported so far in pooled analyses and studies evaluating the optimum duration of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) patients. However, randomized clinical trials dedicated to this specific setting of higher thrombotic risk patients have o...
Tallennettuna:
| Julkaisussa: | Cardiovasc Ther |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7166288/ https://ncbi.nlm.nih.gov/pubmed/32328172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/6495036 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|